• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ARCHITECT HAVAB-IGG; IGG ANTI-HAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ARCHITECT HAVAB-IGG; IGG ANTI-HAV Back to Search Results
Catalog Number 06C29-22
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
Complete patient identifiers: (b)(6).All available patient information has been included.No additional patient details are available.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported false reactive (b)(6) igg results for two patients, when processing on the architect i2000sr.The following data was provided: sid (b)(6): isr52410 initial: 3.25 s/co.Isr51772 retest: 0.69 s/co.Isr52410 retest: 1.13 s/co.Retest with isr52410 at a later date: 0.91 s/co.Sid (b)(6): isr52410 initial: 4.40 s/co.Isr51772 retest: 0.82 s/co.Isr52410 retest: 2.40 s/co.Retest with isr52410 at a later date: 0.37 s/co.No impact to patient management was reported.
 
Manufacturer Narrative
A review of tickets determined there is slightly elevated complaint activity for the architect havab igg reagent, lot number 03402be00.Tracking and trending report review did not identify any related trends.A review of field data for the architect havab igg reagent was performed as well as a review of the performance for the likely cause lot, 03402be00.The review showed that the median and standard deviations to the cutoff of the negative population for the likely cause lot were within established baselines; therefore, the performance of lot 03402be00 was not found to be compromised.Manufacturing documentation was reviewed and no issues were identified.Additionally, labeling was reviewed and sufficiently addresses the customers issue.Based on the investigation, no systemic issue or product deficiency of the architect havab igg reagent was identified.Correction to section d11: concomitant medical products and therapy dates: serial corrected from 03m74-01 to (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB-IGG
Type of Device
IGG ANTI-HAV
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key9280118
MDR Text Key219780474
Report Number3002809144-2019-00811
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/05/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/15/2020
Device Catalogue Number06C29-22
Device Lot Number03402BE00
Was Device Available for Evaluation? Yes
Date Manufacturer Received11/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR, LIST 03M74-01; ARCHITECT I2000SR, LIST 03M74-01; SERIAL (B)(4); SERIAL (B)(4)
-
-